Evidence map›Paper›PMID 20085845›Full record

ArticleVirology2010

Elevated levels of macrophage migration inhibitory factor (MIF) in the plasma of HIV-1-infected patients and in HIV-1-infected cell cultures: a relevant role on viral replication.

Eduardo G Regis, Victor Barreto-de-Souza, Mariza G Morgado, Marcelo T Bozza, Lin Leng, Richard Bucala, Dumith C Bou-Habib

Open access · greenAbstract read
In one paragraph

Article in Virology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Endogenous Peptide Inhibitors of HIV Entry.Advances in experimental medicine and biology · 2022
    Article
  6. Review
  7. Review
  8. Article
  9. Macrophage migration inhibitory factor (MIF) controls cytokine release during respiratory syncytial virus infection in macrophages.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2019
    Article
  10. Low expressionCytokine: X · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Cerebrospinal Fluid Biomarkers of Simian Immunodeficiency Virus Encephalitis : CSF Biomarkers of SIV Encephalitis.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2016
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Eduardo G RegisLaboratory on Thymus Research, Oswaldo Cruz Institute/FIOCRUZ, Rio de Janeiro, RJ, Brazil.
Victor Barreto-de-SouzaLaboratory on Thymus Research, Oswaldo Cruz Institute/FIOCRUZ, Rio de Janeiro, RJ, Brazil.
Mariza G MorgadoLaboratory of AIDS and Molecular Immunology, Oswaldo Cruz Institute/FIOCRUZ, Rio de Janeiro, RJ, Brazil.
Marcelo T BozzaDepartment of Immunology, Institute of Microbiology, Federal University of Rio de Janeiro, RJ, Brazil.
Lin LengYale School of Medicine, CT, USA.
Richard BucalaYale School of Medicine, CT, USA.
Dumith C Bou-HabibLaboratory on Thymus Research, Oswaldo Cruz Institute/FIOCRUZ, Rio de Janeiro, RJ, Brazil. Electronic address: dumith@ioc.fiocruz.br.
Fundação Oswaldo Cruz · BRYale University · USUniversidade Federal do Rio de Janeiro · BR

Funding

Mechanisms of Rheumatoid Synovial Fibroblast ActivationR01AR049610 · NIAMS · YALE UNIVERSITY · PI BUCALA, RICHARD J · 2002 to 2018
$5.0M
MIF AND THE HOST RESPONSE TO INFECTIONR01AI042310 · NIAID · YALE UNIVERSITY · PI BUCALA, RICHARD J · 1998 to 2013
$4.3M
NIAID NIH HHS 2 RO1 AI42310NIAID NIH HHS R01 AI042310NIAMS NIH HHS R01 AR049610
6 · The paper itself

Abstract

The cytokine macrophage migration inhibitory factor (MIF) is involved in the pathogenesis of inflammatory and infectious diseases, however its role in HIV-1 infection is unknown. Here we show that HIV-1-infected patients present elevated plasma levels of MIF, that HIV-1-infected peripheral blood mononuclear cells (PBMCs) release a greater amount of MIF, and that the HIV-1 envelope glycoprotein gp120 induces MIF secretion from uninfected PBMCs. The HIV-1 replication in PBMCs declines when these cells are treated with anti-MIF antibodies, and exposure of HIV-1-infected cells to the ABC-transporter inhibitor probenecid results in inhibition of MIF secretion. The addition of recombinant MIF (rhMIF) to HIV-1-infected PBMCs enhances viral replication of CCR5- or CXCR4-tropic HIV-1 isolates. Using a T CD4(+) cell lineage containing an HIV long terminal repeats (LTR)-Luciferase construct, we detected that rhMIF promotes transcription from HIV-1 LTR. Our results show that HIV-1 induces MIF secretion and suggest that MIF influences the HIV-1 biology through activation of HIV-1 LTR.

Indexed as

HIV-1ATP-Binding Cassette TransportersCell LineHIV Envelope Protein gp120HIV InfectionsHIV Long Terminal RepeatHumansIntramolecular OxidoreductasesLeukocytes, MononuclearMacrophage Migration-Inhibitory FactorsProbenecidRecombinant ProteinsVirus ReplicationATP-Binding Cassette Transportersgp120 protein, Human immunodeficiency virus 1HIV Envelope Protein gp120Intramolecular OxidoreductasesMacrophage Migration-Inhibitory FactorsMIF protein, humanProbenecidRecombinant Proteins

Identifiers

PMID20085845
PMCPMC3140709
OpenAlexW2063905670

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.